Leptin in congenital or HIV-associated lipodystrophy and metabolic syndrome: A need for more mechanistic studies and large, randomized, placebo-controlled trials

被引：14

作者：

Foo, Joo-Pin ^{[1
]}

Mantzoros, Christos S. ^{[1
,2
]}

机构：

[1] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Endocrinol Diabet & Metab,Dept Internal Med, Boston, MA 02215 USA

[2] Harvard Univ, Dept Internal Med, Sch Med, VA Boston Healthcare Syst,Sect Endocrinol, Boston, MA USA

来源：

METABOLISM-CLINICAL AND EXPERIMENTAL | 2012年 / 61卷 / 10期

关键词：

ACTIVE ANTIRETROVIRAL THERAPY; ACQUIRED-IMMUNODEFICIENCY-SYNDROME; REVERSES INSULIN-RESISTANCE; VIRUS-INFECTED PATIENTS; RECOMBINANT HUMAN LEPTIN; HORMONE-RELEASING FACTOR; MYOCARDIAL-INFARCTION; PROTEASE-INHIBITOR; DOUBLE-BLIND; REPLACEMENT THERAPY;

D O I：

10.1016/j.metabol.2012.04.013

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

收藏

页码：1331 / 1336

页数：6

相关论文

共 65 条

[1]

Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy [J].

Addy, CL ;

Gavrila, A ;

Tsiodras, S ;

Brodovicz, K ;

Karchmer, AW ;

Mantzoros, CS .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (02) :627-636

[2]

Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes [J].

Arioglu, E ;

Duncan-Morin, J ;

Sebring, N ;

Rother, KI ;

Gottlieb, N ;

Lieberman, J ;

Herion, D ;

Kleiner, DE ;

Reynolds, J ;

Premkumar, A ;

Sumner, AE ;

Hoofnagle, J ;

Reitman, ML ;

Taylor, SI .

ANNALS OF INTERNAL MEDICINE, 2000, 133 (04) :263-274

[3]

Site and mechanism of leptin action in a rodent form of congenital lipodystrophy [J].

Asilmaz, E ;

Cohen, P ;

Miyazaki, M ;

Dobrzyn, P ;

Ueki, K ;

Fayzikhodjaeva, G ;

Soukas, AA ;

Kahn, CR ;

Ntambi, JM ;

Socci, ND ;

Friedman, JM .

JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (03) :414-424

[4]

HIV and metabolic syndrome - A comparison with the general population [J].

Bonfanti, Paolo ;

Giannattasio, Cristina ;

Ricci, Elena ;

Facchetti, Rita ;

Rosella, Elena ;

Franzetti, Marzia ;

Cordier, Laura ;

Pusterla, Luigi ;

Bombelli, Michele ;

Sega, Roberto ;

Quirino, Tiziana ;

Mancia, Giuseppe .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 45 (04) :426-431

[5]

Hyperlipidaemia in patients with HIV-1 infection receiving highly active antiretroviral therapy: epidemiology, pathogenesis, clinical course and management [J].

Calza, L ;

Manfredi, R ;

Chiodo, F .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2003, 22 (02) :89-99

[6]

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study [J].

Carr, A ;

Samaras, K ;

Thorisdottir, A ;

Kaufmann, GR ;

Chisholm, DJ ;

Cooper, DA .

LANCET, 1999, 353 (9170) :2093-2099

[7]

No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial [J].

Carr, A ;

Workman, C ;

Carey, D ;

Rogers, G ;

Martin, A ;

Baker, D ;

Wand, H ;

Law, M ;

Samaras, K ;

Emery, S ;

Cooper, DA .

LANCET, 2004, 363 (9407) :429-438

[8]

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance [J].

Carr, A ;

Samaras, K ;

Chisholm, DJ ;

Cooper, DA .

LANCET, 1998, 351 (9119) :1881-1883

[9]

A randomized, placebo-controlled trial of rosiglitazone for HIV-related lipoatrophy [J].

Cavalcanti, Rodrigo B. ;

Raboud, Janet ;

Shen, Sandy ;

Kain, Kevin C. ;

Cheung, Angela ;

Walmsley, Sharon .

JOURNAL OF INFECTIOUS DISEASES, 2007, 195 (12) :1754-1761

[10]

Abacavir and cardiovascular risk: Reviewing the evidence [J].

Costagliola D. ;

Lang S. ;

Mary-Krause M. ;

Boccara F. .

Current HIV/AIDS Reports, 2010, 7 (3) :127-133

← 1 2 3 4 5 6 7 →